179 related articles for article (PubMed ID: 36336681)
1. PTEN regulates invasiveness in pancreatic neuroendocrine tumors through DUSP19-mediated VEGFR3 dephosphorylation.
Chang TM; Chu PY; Lin HY; Huang KW; Hung WC; Shan YS; Chen LT; Tsai HJ
J Biomed Sci; 2022 Nov; 29(1):92. PubMed ID: 36336681
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
[TBL] [Abstract][Full Text] [Related]
3. c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
Chang TM; Chu PY; Hung WC; Shan YS; Lin HY; Huang KW; Chang JS; Chen LT; Tsai HJ
Cancer Sci; 2021 Jan; 112(1):243-253. PubMed ID: 33128283
[TBL] [Abstract][Full Text] [Related]
4. VEGFR3 inhibition chemosensitizes lung adenocarcinoma A549 cells in the tumor-associated macrophage microenvironment through upregulation of p53 and PTEN.
Li Y; Weng Y; Zhong L; Chong H; Chen S; Sun Y; Li W; Shi Q
Oncol Rep; 2017 Nov; 38(5):2761-2773. PubMed ID: 29048623
[TBL] [Abstract][Full Text] [Related]
5. Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer.
Chaudary N; Milosevic M; Hill RP
Gynecol Oncol; 2011 Nov; 123(2):393-400. PubMed ID: 21839498
[TBL] [Abstract][Full Text] [Related]
6. [High expression of VEGFR3 is positively associated with poor prognosis in lung adenocarcinoma].
Li J; Zhang W; Xia H; Liu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1023-1029. PubMed ID: 31878999
[TBL] [Abstract][Full Text] [Related]
7. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
8. Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis.
Wang J; Huang Y; Zhang J; Wei Y; Mahoud S; Bakheet AM; Wang L; Zhou S; Tang J
Clin Chim Acta; 2016 Oct; 461():165-71. PubMed ID: 27527412
[TBL] [Abstract][Full Text] [Related]
9. VEGFC/VEGFR3 Signaling Regulates Mouse Spermatogonial Cell Proliferation via the Activation of AKT/MAPK and Cyclin D1 Pathway and Mediates the Apoptosis by affecting Caspase 3/9 and Bcl-2.
Zhao L; Zhu Z; Yao C; Huang Y; Zhi E; Chen H; Tian R; Li P; Yuan Q; Xue Y; Wan Z; Yang C; Gong Y; He Z; Li Z
Cell Cycle; 2018; 17(2):225-239. PubMed ID: 29169284
[TBL] [Abstract][Full Text] [Related]
10. miR-431 Promotes Metastasis of Pancreatic Neuroendocrine Tumors by Targeting DAB2 Interacting Protein, a Ras GTPase Activating Protein Tumor Suppressor.
Zhang T; Choi S; Zhang T; Chen Z; Chi Y; Huang S; Xiang JZ; Du YN
Am J Pathol; 2020 Mar; 190(3):689-701. PubMed ID: 31953039
[TBL] [Abstract][Full Text] [Related]
11. Tumor Necrosis Factor-
Chen X; Lin L; Wu Q; Li S; Wang H; Sun Y
Mediators Inflamm; 2023; 2023():5679966. PubMed ID: 37124061
[TBL] [Abstract][Full Text] [Related]
12. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis.
Le Guen L; Karpanen T; Schulte D; Harris NC; Koltowska K; Roukens G; Bower NI; van Impel A; Stacker SA; Achen MG; Schulte-Merker S; Hogan BM
Development; 2014 Mar; 141(6):1239-49. PubMed ID: 24523457
[TBL] [Abstract][Full Text] [Related]
13. The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors.
Chang TM; Shan YS; Chu PY; Jiang SS; Hung WC; Chen YL; Tu HC; Lin HY; Tsai HJ; Chen LT
Oncotarget; 2017 Nov; 8(58):98068-98083. PubMed ID: 29228674
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling.
Ou JJ; Wei X; Peng Y; Zha L; Zhou RB; Shi H; Zhou Q; Liang HJ
Cancer Lett; 2015 Mar; 358(2):200-209. PubMed ID: 25543087
[TBL] [Abstract][Full Text] [Related]
15. Altered PTEN, ATRX, CHGA, CHGB, and TP53 expression are associated with aggressive VHL-associated pancreatic neuroendocrine tumors.
Weisbrod AB; Zhang L; Jain M; Barak S; Quezado MM; Kebebew E
Horm Cancer; 2013 Jun; 4(3):165-75. PubMed ID: 23361940
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor c promotes ovarian carcinoma progression through paracrine and autocrine mechanisms.
Decio A; Taraboletti G; Patton V; Alzani R; Perego P; Fruscio R; Jürgensmeier JM; Giavazzi R; Belotti D
Am J Pathol; 2014 Apr; 184(4):1050-1061. PubMed ID: 24508126
[TBL] [Abstract][Full Text] [Related]
17. C/EBP-δ regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1α.
Min Y; Ghose S; Boelte K; Li J; Yang L; Lin PC
Oncogene; 2011 Dec; 30(49):4901-9. PubMed ID: 21666710
[TBL] [Abstract][Full Text] [Related]
18. Soluble Vegfr3 gene therapy suppresses multi-organ metastasis in a mouse mammary cancer model.
Shibata MA; Shibata E; Tanaka Y; Shiraoka C; Kondo Y
Cancer Sci; 2020 Aug; 111(8):2837-2849. PubMed ID: 32539229
[TBL] [Abstract][Full Text] [Related]
19. Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer.
Tacconi C; Ungaro F; Correale C; Arena V; Massimino L; Detmar M; Spinelli A; Carvello M; Mazzone M; Oliveira AI; Rubbino F; Garlatti V; Spanò S; Lugli E; Colombo FS; Malesci A; Peyrin-Biroulet L; Vetrano S; Danese S; D'Alessio S
Cancer Res; 2019 Aug; 79(16):4196-4210. PubMed ID: 31239267
[TBL] [Abstract][Full Text] [Related]
20. Developmental expression of vascular endothelial growth factor receptor 3 and vascular endothelial growth factor C in forebrain.
Ward MC; Cunningham AM
Neuroscience; 2015 Sep; 303():544-57. PubMed ID: 25943477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
